National Strategies to Decrease the Burden of Diabetes and Its Complications

Current Diabetes Reports

Volumn 15, Issue 9, 2015, Pages

  Haw, J Sonya ^a   Tantry, Shyamanand ^a   Vellanki, Priyathama ^a   Pasquel, Francisco J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complications; Cost effectiveness; Diabetes; National strategies; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AFRICAN AMERICAN; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; FOOT AMPUTATION; GLYCEMIC CONTROL; HEALTH AUXILIARY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH CENTER; HEALTH DISPARITY; HEALTH INSURANCE; HEART REHABILITATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; LONG TERM CARE; MASS SCREENING; MICROALBUMINURIA; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; RISK REDUCTION; SELF CARE; SOCIAL MEDIA; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TOTAL QUALITY MANAGEMENT; TRANSLATIONAL RESEARCH; UNITED STATES; WEIGHT REDUCTION; COST BENEFIT ANALYSIS; DIABETES COMPLICATIONS; ECONOMICS; PUBLIC HEALTH;

COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; NATIONAL HEALTH PROGRAMS;

EID: 84938822989     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-015-0637-y     Document Type: Review

References (72)

1. Huang ES, Basu A, O’Grady M, et al. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009;32:2225–9.
2. Jenkins C, McNary S, Carlson BA, et al. Reducing disparities for African Americans with diabetes: progress made by the REACH 2010 Charleston and Georgetown Diabetes Coalition. Public Health Rep. 2004;119:322–30.
3. Chin MH. Quality improvement implementation and disparities: the case of the health disparities collaboratives. Med Care. 2010;48:668–75.
4. Chin MH, Drum ML, Guillen M, et al. Improving and sustaining diabetes care in community health centers with the health disparities collaboratives. Med Care. 2007;45:1135–43.
5. Landon BE, Hicks LS, O’Malley AJ, et al. Improving the management of chronic disease at community health centers. N Engl J Med. 2007;356:921–34.
6. Wang A, Wolf M, Carlyle R, et al. The North Carolina experience with the diabetes health disparities collaboratives. Jt Comm J Qual Saf. 2004;30:396–404.
7. Chin MH, Kirchhoff AC, Schlotthauer AE, et al. Sustaining quality improvement in community health centers: perceptions of leaders and staff. J Ambul Care Manage. 2008;31:319–29.
8. Lewis MA, Bann CM, Karns SA, et al. Cross-site evaluation of the alliance to reduce disparities in diabetes: clinical and patient-reported outcomes. Health Promot Pract. 2014;15:92S–102.
9. Peek ME, Wilkes AE, Roberson TS, et al. Early lessons from an initiative on Chicago’s South Side to reduce disparities in diabetes care and outcomes. Health Aff (Project Hope). 2012;31:177–86.
10. Kilo CM. A framework for collaborative improvement: lessons from the Institute for Healthcare Improvement’s breakthrough series. Qual Manag Health Care. 1998;6:1–13.
11. Wagner EH, Glasgow RE, Davis C, et al. Quality improvement in chronic illness care: a collaborative approach. Jt Comm J Qual Improv. 2001;27:63–80.
12. Daniel DM, Norman J, Davis C, et al. A state-level application of the chronic illness breakthrough series: results from two collaboratives on diabetes in Washington State. Jt Comm J Qual Saf. 2004;30:69–79.
13. Brownson CA, Hoerger TJ, Fisher EB, et al. Cost-effectiveness of diabetes self-management programs in community primary care settings. Diabetes Educ. 2009;35:761–9.
14. Fisher EB, Brownson CA, O’Toole ML, et al. Ecological approaches to self-management: the case of diabetes. Am J Public Health. 2005;95:1523–35.
15. Ingram M, Torres E, Redondo F, et al. The impact of promotoras on social support and glycemic control among members of a farmworker community on the US-Mexico border. Diabetes Educ. 2007;33:172S–8.
16. Joshu CE, Rangel L, Garcia O, et al. Integration of a promotora-led self-management program into a system of care. Diabetes Educ. 2007;33:151S–8.
17. Thompson JR, Horton C, Flores C. Advancing diabetes self-management in the Mexican American population: a community health worker model in a primary care setting. Diabetes Educ. 2007;33:159S–65.
18. Wilson C, Gilliland S, Cullen T, et al. Diabetes outcomes in the Indian health system during the era of the special diabetes program for Indians and the Government Performance and Results Act. Am J Public Health. 2005;95:1518–22.
19. Ramesh M, Schraer C, Mayer AM, et al. Effect of special diabetes program for Indians funding on system changes in diabetes care and outcomes among American Indian/Alaska Native people 1994-2004. Int J Circumpolar Health. 2008;67:203–12.
20. Jiang L, Manson SM, Beals J, et al. Translating the Diabetes Prevention Program into American Indian and Alaska Native communities: results from the Special Diabetes Program for Indians Diabetes Prevention demonstration project. Childhood Obes (Print). 2013;36:2027–34.
21. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
22. Gallivan J, Lising M, Ammary NJ, et al. The national diabetes education program’s “Control Your Diabetes. For Life”. Campaign: design, implementation, and lessons learned. Soc Mark Q. 2007;13:65–82.
23. Griffey S, Piccinino L, Gallivan J, et al. Applying national survey results for strategic planning and program improvement: the National Diabetes Education Program. Eval Program Plan. 2015;48:83–9.
24. Gallivan J, Greenberg R, Brown C. The National Diabetes Education Program evaluation framework: how to design an evaluation of a multifaceted public health education program. Prev Chronic Dis. 2008;5:A134.
25. Jenkins C, Pope C, Magwood G, et al. Expanding the chronic care framework to improve diabetes management: the REACH case study. Progress Commun Health Partnerships: Res Educ Action. 2010;4:65–79.
26. Spencer MS, Rosland AM, Kieffer EC, et al. Effectiveness of a community health worker intervention among African American and Latino adults with type 2 diabetes: a randomized controlled trial. Am J Public Health. 2011;101:2253–60.
27. Standards of medical care in diabetes—2015: summary of revisions. Diabetes Care 2015;38 Suppl:S4
28. Jenkins C, Myers P, Heidari K, et al. Efforts to decrease diabetes-related amputations in African Americans by the racial and ethnic approaches to Community Health Charleston and Georgetown Diabetes Coalition. Fam Commun Health. 2011;34 Suppl 1:S63–78.
29. Chin MH, Cook S, Drum ML, et al. Improving diabetes care in midwest community health centers with the health disparities collaborative. Diabetes Care. 2004;27:2–8.
30. Benedetti R, Flock B, Pedersen S, et al. Improved clinical outcomes for fee-for-service physician practices participating in a diabetes care collaborative. Jt Comm J Qual Saf. 2004;30:187–94.
31. Plantinga LC, Johansen K, Crews DC, et al. Association of CKD with disability in the United States. Am J kidney Dis. 2011;57:212–27.
32. Whaley-Connell AT, Sowers JR, Stevens LA, et al. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008;51:S13–20.
33. American Diabetes A. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–46.
34. Moore K, Jiang L, Manson SM, et al. Case management to reduce cardiovascular disease risk in American Indians and Alaska Natives with diabetes: results from the Special Diabetes Program for Indians Healthy Heart Demonstration Project. Am J Public Health. 2014;104:e158–64. SDPI program with CV risk assessment focus showing improvement in intermediate parameters.
35. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–86.
36. Saaristo T, Peltonen M, Keinanen-Kiukaanniemi S, et al. National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health. 2007;66:101–12.
37. McTigue KM, Conroy MB, Bigi L, et al. Weight loss through living well: translating an effective lifestyle intervention into clinical practice. Diabetes Educ. 2009;35:199–208.
38. Whittemore R, Melkus G, Wagner J, et al. Translating the diabetes prevention program to primary care: a pilot study. Nurs Res. 2009;58:2–12.
39. McBride PE, Einerson JA, Grant H, et al. Putting the Diabetes Prevention Program into practice: a program for weight loss and cardiovascular risk reduction for patients with metabolic syndrome or type 2 diabetes mellitus. J Nutr Health Aging. 2008;12:745s–9.
40. Boltri JM, Davis-Smith M, Okosun IS, et al. Translation of the National Institutes of Health Diabetes Prevention Program in African American churches. J Natl Med Assoc. 2011;103:194–202.
41. Boltri JM, Davis-Smith YM, Seale JP, et al. Diabetes prevention in a faith-based setting: results of translational research. J Public Health Manag Pract: JPHMP. 2008;14:29–32.
42. Faridi Z, Shuval K, Njike VY, et al. Partners reducing effects of diabetes (PREDICT): a diabetes prevention physical activity and dietary intervention through African-American churches. Health Educ Res. 2010;25:306–15.
43. Ackermann RT, Finch EA, Caffrey HM, et al. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study. Chronic Illness. 2011;7:279–90.
44. Bozack A, Millstein S, Garcel JM, et al. Implementation and outcomes of the New York State YMCA Diabetes Prevention Program: a multisite community-based translation, 2010–2012. Prev Chron Dis. 2014;11, E115.
45. Amundson HA, Butcher MK, Gohdes D, et al. Translating the diabetes prevention program into practice in the general community: findings from the Montana Cardiovascular Disease and Diabetes Prevention Program. Diabetes Educ. 2009;35:209–23.
46. Katula JA, Vitolins MZ, Morgan TM, et al. The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial. Am J Prev Med. 2013;44:S324–32.
47. West DS, Bursac Z, Cornell CE, et al. Lay health educators translate a weight-loss intervention in senior centers: a randomized controlled trial. Am J Prev Med. 2011;41:385–91.
48. Walton JW, Snead CA, Collinsworth AW, et al. Reducing diabetes disparities through the implementation of a community health worker-led diabetes self-management education program. Fam Community Health. 2012;35:161–71.
49. Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program. Am J Prev Med. 2013;44:S346–51.
50. Vojta D, De Sa J, Prospect T, et al. Effective interventions for stemming the growing crisis of diabetes and prediabetes: a national payer’s perspective. Health Aff. 2012;31:20–6.
51. Centers for Disease Control and Prevention. National Diabetes Prevention Program [internet home page]. Atlanta (GA): CDC. Available from: http://www.cdc.gov/diabetes/prevention/index.htm.
52. Li R, Zhang P, Barker LE, et al. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33:1872–94.
53. Huang ES, Zhang Q, Brown SE, et al. The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers. Health Serv Res. 2007;42:2174–93. discussion 2294-2323.
54. Woolf SH. A closer look at the economic argument for disease prevention. JAMA. 2009;301:536–8.
55. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.
56. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–44.
57. Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–97.
58. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 2003;26:2518–23
59. Caro JJ, Getsios D, Caro I, et al. Economic evaluation of therapeutic interventions to prevent type 2 diabetes in Canada. Diabetic Med J Br Diabetic Assoc. 2004;21:1229–36.
60. Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann Intern Med. 2005;143:251–64.
61. Herman WH, Hoerger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142:323–32.
62. Palmer AJ, Roze S, Valentine WJ, et al. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom. Clin Ther. 2004;26:304–21.
63. Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff. 2012;31:67–75.
64. Ackermann RT, Holmes AM, Saha C. Designing a natural experiment to evaluate a national health care-community partnership to prevent type 2 diabetes. Prev Chron Dis. 2013;10:E12. Translational study design to implement the DPP lifestyle intervention model in a real-world setting.
65. Zhuo X, Zhang P, Gregg EW, et al. A nationwide community-based lifestyle program could delay or prevent type 2 diabetes cases and save $5.7 billion in 25 years. Health Aff (Project Hope). 2012;31:50–60.
66. Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2:474–80. Potential for long-term impact of lifestyle intervention beyond diabetes prevention.
67. Eggleston EM, Klompas M. Rational use of electronic health records for diabetes population management. Curr Diabetes Rep. 2014;14:479.
68. Narayan KM, Benjamin E, Gregg EW, et al. Diabetes translation research: where are we and where do we want to be? Ann Intern Med. 2004;140:958–63.
69. Huang ES, Brown SES, Zhang JX, et al. The cost consequences of improving diabetes care: the community health center experience. Jt Comm J Qual Patient Saf. 2008;34:138–46.
70. Stark Casagrande S, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013;36:2271–9. Representative national sample showing limited success in achieving ABC goals.
71. Berwick DM, Nolan TW, Whittington J. The triple aim: care, health, and cost. Health Aff (Project Hope). 2008;27:759–69.
72. Two Feathers J, Kieffer EC, Palmisano G, et al. Racial and Ethnic Approaches to Community Health (REACH) Detroit partnership: improving diabetes-related outcomes among African American and Latino adults. Am J Public Health. 2005;95:1552–60.